TMEM149 Activators

TMEM149 can engage various intracellular signaling pathways, leading to its activation through phosphorylation and other post-translational modifications. Phorbol 12-myristate 13-acetate (PMA) and 1,2-Dioctanoyl-sn-glycerol (DiC8), both function as activators of protein kinase C (PKC), a family of enzymes that can phosphorylate a wide range of target proteins including TMEM149. PKC activation by these chemicals leads to a cascade of phosphorylation events, where TMEM149 can be a substrate, resulting in its activation. Forskolin, by increasing intracellular cyclic AMP (cAMP) levels, activates protein kinase A (PKA) which can also target TMEM149 for phosphorylation, thus activating it. Similarly, Isoproterenol raises cAMP levels and activates PKA, suggesting a similar activation pathway for TMEM149. Ionomycin, by increasing intracellular calcium, activates calcium-dependent kinases, which can then phosphorylate TMEM149, altering its activity.

Anisomycin, through its activation of the MAPK/ERK pathway, initiates a signaling cascade that can lead to the activation of kinases capable of phosphorylating TMEM149. Okadaic acid and Calyculin A, as phosphatase inhibitors, prevent the dephosphorylation of proteins, thereby contributing to a phosphorylated and active state of TMEM149. Phosphatidic acid, a lipid-derived secondary messenger, can activate PKC, possibly leading to the phosphorylation and activation of TMEM149. Epidermal Growth Factor (EGF) stimulates the EGFR pathway, which activates a variety of kinases, some of which may target TMEM149. N6-Benzoyladenosine-3',5'-cyclic monophosphate (6-Bnz-cAMP) serves as a cAMP analog and activates PKA, which could phosphorylate TMEM149, resulting in its activation. Lastly, Bryostatin 1 modulates the activity of PKC, suggesting another avenue through which TMEM149 may be activated by phosphorylation within PKC-regulated pathways.